comparemela.com
Home
Live Updates
Thrombolysis Not Necessary in Mild Nondisabling Stroke: ARAMIS : comparemela.com
Thrombolysis Not Necessary in Mild Nondisabling Stroke: ARAMIS
Dual antiplatelet treatment was noninferior to thrombolysis with regard to functional outcome at 90 days for Chinese patients with minor nondisabling stroke.
Related Keywords
Cherry Hill
,
New Jersey
,
United States
,
Texas
,
Boston
,
Massachusetts
,
China
,
University Of Cincinnati
,
Ohio
,
Dallas
,
Chinese
,
American
,
Tudor Jovin
,
Pooja Khatri
,
Thanh Nguyen
,
National Institutes Of Health Stroke Scale
,
International Stroke Conference
,
Boston Medical Center
,
Cooper Neurological Institute
,
American Heart Association Stroke
,
Among Chinese
,
Medscape Cardiology
,
National Institutes
,
Health Stroke Scale
,
American Heart
,
American Stroke Association
,
Modified Rankin Scale
,
Antiplatelet Therapy Now Standard
,
Stroke
,
Erebrovascular Accident
,
Va Cerebrovascular Accident
,
Cerebrovascular Disease
,
Thrombolytic Therapy
,
Thromboembolism
,
Ischemic Stroke
,
Aspirin
,
Intravenous Iv
,
Intravenous
,
Tv
,
Clinical Guidelines
,
Guidelines
,
Tissue Plasminogen Activator Tpa
,
Pa Tissue Plasminogen Activator
,
Intracranial Hemorrhage
,
Intracranial Bleeding
,
Heart
,
Hemorrhage
,
Bleeding
,
Hospitals
,
Recurrent Str
,
comparemela.com © 2020. All Rights Reserved.